Schistosomes express a family of integral membrane proteins, called tetraspanins (TSPs), in the outer surface membranes of the tegument. Two of these tetraspanins, Sm-TSP-1 and Sm-TSP-2, confer protection as vaccines in mice, and individuals who are naturally resistant to S. mansoni infection mount a strong IgG response to Sm-TSP-2. To determine their functions in the tegument of S. mansoni we used RNA interference to silence expression of Sm-tsp-1 and Sm-tsp-2 mRNAs. Soaking of parasites in Sm-tsp dsRNAs resulted in 61% (p = 0.009) and 74% (p = 0.009) reductions in Sm-tsp-1 and Sm-tsp-2 transcription levels, respectively, in adult worms, and 67%–75% (p = 0.011) and 69%–89% (p = 0.004) reductions in Sm-tsp-1 and Sm-tsp-2 transcription levels, respectively, in schistosomula compared to worms treated with irrelevant control (luciferase) dsRNA. Ultrastructural morphology of adult worms treated in vitro with Sm-tsp-2 dsRNA displayed a distinctly vacuolated and thinner tegument compared with controls. Schistosomula exposed in vitro to Sm-tsp-2 dsRNA had a significantly thinner and more vacuolated tegument, and morphology consistent with a failure of tegumentary invaginations to close. Injection of mice with schistosomula that had been electroporated with Sm-tsp-1 and Sm-tsp-2 dsRNAs resulted in 61% (p = 0.005) and 83% (p = 0.002) reductions in the numbers of parasites recovered from the mesenteries four weeks later when compared to dsRNA-treated controls. These results imply that tetraspanins play important structural roles impacting tegument development, maturation or stability.
Schistosomes, or blood flukes, reside in the blood vessels surrounding the liver and bowel of their human hosts. They infect 200 million people and kill many thousands each year in developing countries. The parasites cover themselves in a unique series of cell membranes called the tegument. Molecules in the tegument membranes are a major target for the development of new drugs and vaccines against the parasite. Here we show that at least one member of a family of tegument membrane proteins called tetraspanins, Sm-TSP-2, is integral to the proper formation of the tegument and subsequent survival of the parasite in its human host, providing a potential mechanism by which a vaccine based on Sm-TSP-2 protects immunized hosts.
Citation: Tran MH, Freitas TC, Cooper L, Gaze S, Gatton ML, Jones MK, et al. (2010) Suppression of mRNAs Encoding Tegument Tetraspanins from Schistosoma mansoni Results in Impaired Tegument Turnover. PLoS Pathog6(4): e1000840. https://doi.org/10.1371/journal.ppat.1000840
Editor: Elisabetta Ullu, Yale University, United States of America
Received: September 29, 2009; Accepted: March 3, 2010; Published: April 15, 2010
Copyright: © 2010 Tran et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work is supported by the Australian-American Fulbright Commission (MHT), Australian National Health and Medical Research Council (NHMRC) grant #496600 to AL, National Institutes of Health (NIH) grants AI075266 and AI082548 to EJP and NIAID contract NO1-A1-30026. AL is supported by a senior research fellowship from NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Schistosomes are parasitic trematodes that cause chronic infection in over 207 million people in 76 developing tropical countries. Schistosomiasis is generally associated with poverty, poor water supply and inadequate sanitation . Infection rates and intensities are high in early childhood, peak around 8 to 15 years and decrease in adulthood . Despite effective and inexpensive widespread treatment with the anthelmintic drug praziquantel for over 20 years, this parasitic disease still causes more than 250,000 deaths per year and accounts for 1.7 to 4.5 million disability-adjusted life years (DALYs) lost annually .
Humans become infected with schistosomes when they are exposed to free-living cercariae in fresh water. Cercariae penetrate the skin, shed their tails and transform into schistosomula, which reside in the dermis of the skin before entering the blood capillaries to migrate through the vasculature to the portal venous system where they mature into adult worms . The outer surface of schistosomula and adult worms, the tegument, is a multinucleated syncitium that contains tegumental cell bodies situated below the muscular layers. During transformation from cercaria to schistosomula, the outer surface of the tegument (the interface with the host) is remodeled from a single membrane with a prominent glycocalyx into an unusual double membrane (or “heptalaminate”) structure . This double membrane is widely believed to play an essential role in the ability of schistosomes to evade the host immune system, a characteristic that allows them to live for years within their hosts . The outer of the two surface membranes also has the ability to adsorb host blood molecules, masking its non-self status thereby contributing to immune evasion and prolonged survival . We believe that tegumental proteins are ideal targets for immunological and pharmacological intervention . The generation of a large number of S. mansoni expressed sequence tags  and the recently completed genome sequence , in combination with advances in characterizing the tegument proteome has led to the discovery of many tegument specific proteins . Among them are a group of membrane proteins called tetraspanins, which are highly expressed in the outer tegument membrane of adult schistosomes , . To date, five tetraspanin cDNAs have been described from S. mansoni, namely Sm-23 , Sm-tsp-1 and Sm-tsp-2 , Sm-tetraspanin-B and Sm-tetraspanin-C .
Tetraspanins are a large superfamily of surface-associated membrane proteins characterized by the conserved structure of four hydrophobic transmembrane domains, a small and large extracellular loop, an interconnecting intracellular loop, and cytoplasmic amino- and carboxyl- termini . Tetraspanins undergo post-translational modification in which palmitate is bound to the membrane proximal cysteine residues and associates with cholesterol-rich domains . This process enables tetraspanins to play key roles in molecular organization of cell membranes, interacting with one another and also specific partner proteins such as integrins, MHC and co-stimulatory molecules to form large signal transducing complexes termed tetraspanin-enriched microdomains (TEMs) . Tetraspanins are widely distributed in many cell types but their physiological roles are mostly unknown. Several lines of evidence have implicated tetraspanins in the regulation of cell adhesion, differentiation, motility, aggregation, cell signaling and sperm-egg fusion , , , . They have been linked to various pathological processes including lymphocyte activation , cancer , fertilization , , and interactions between pathogens and host cells such as HIV , HCV  and Plasmodium .
We previously identified two cDNAs, Sm-tsp-1 (Sm01494) and Sm-tsp-2 (Sm12366), in adult S. mansoni using signal sequence trapping , and showed that both of these tetraspanins were expressed in the tegument of the adult parasite . Other authors confirmed the surface expression of these tetraspanins using various mass spectrometric approaches to characterize the schistosome surface , , . We expressed the large extracellular loop of Sm-TSP-1 and Sm-TSP-2 in E. coli and used the soluble recombinant proteins to immunize mice and then challenged them with cercariae. Mice vaccinated with recombinant Sm-TSP-1 and Sm-TSP-2 had significantly reduced adult worm, liver egg and fecal egg burdens . Moreover, strong IgG1 and IgG3 antibody responses against Sm-TSP-2 were detected in sera of individuals deemed putatively resistant (PR) to S. mansoni in comparison to sera from chronically infected individuals .
Despite their promise as vaccines against schistosomiasis, the functions of Sm-TSP-1 and Sm-TSP-2 have not yet been elucidated. We therefore employed RNA interference (RNAi) to explore the roles of Sm-tsp-1 and tsp-2 in larval and adult S. mansoni. RNAi has been utilized with S. mansoni to suppress endogenous gene expression in schistosomula , adult worms , eggs  and sporocysts . Here, we show that RNAi results in reductions in expression of Sm-tsp-1 and tsp-2 mRNAs in schistosomula and adult worms, and malformation of the tegument in worms cultured in vitro. Moreover, silencing of tsp-1 and tsp-2 expression in schistosomula results in up to 90% fewer worms maturing to adulthood when introduced into mice compared with parasites exposed to control dsRNAs, highlighting their essential roles in tegument biogenesis and maintenance and further supporting the development of novel therapies targeting these genes and their protein products.
Developmental expression of Sm-tsp-1 and Sm-tsp-2 in S. mansoni
Expression of Sm-tsp-1 and Sm-tsp-2 mRNAs in different stages of the S. mansoni life cycle was determined relative to control Sm-α-tubilin mRNA using qRT-PCR. Sm-tsp-1 and Sm-tsp-2 mRNAs were detected in all stages of the schistosome life cycle with higher levels identified in eggs, miracidia and cercariae than in 5-day old schistosomula, males and female worms for tsp-1; a similar expression profile was observed for tsp-2 but gene expression was notably reduced in cercariae (Figure 1). Interestingly, the highest level of Sm-tsp-1 expression was detected in cercariae whereas Sm-tsp-2 expression was lowest in cercariae.
Expression of Sm-TSP-1 and Sm-TSP-2 in the tegument of schistosomula
We previously demonstrated that Sm-TSP-1 and Sm-TSP-2 are expressed on the tegument surface membrane of adult worms . The tegument is fully formed by 3h after cercarial transformation , so to determine whether these TSPs are expressed in the tegument at this early stage after host entry and whether they are accessible to antibodies on live parasites, we probed live newly transformed schistosomula with antibodies against both proteins. Both Sm-TSP-1 and Sm-TSP-2 were detected over the entire surface tegument of live schistosomula when probed with mouse anti-TSP-1 or -TSP-2 sera followed by FITC-labelled anti-mouse IgG (Figure 2).
Immunofluorescent labelling of live 3 h schistosomula with antisera raised against Sm-TSP-1 (A) and Sm-TSP-2 (B), and control pre-immune serum (C) followed by anti-mouse Ig-FITC. Schistosomula are shown in bright-field and FITC stained. Scale = 50 µm.
dsRNA-mediated knockdown of Sm-tsp expression in adult worms
Adult worms soaked for 7 days in Sm-tsp-1 dsRNA had a 61% (p = 0.009) reduction in Sm-tsp-1 mRNA expression compared to parasites soaked in control dsRNA (Figure 3A). A 74% (p = 0.009) reduction in Sm-tsp-2 mRNA levels was detected in worms that were cultured in media containing Sm-tsp-2 dsRNA compared to parasites soaked in luciferase dsRNA (Figure 3B). Parasites were visually monitored for motility on a daily basis but no differences were detected between groups (not shown).
dsRNA-mediated knockdown of Sm-tsp expression in schistosomula
Soaking of 3 h old schistosomula in Sm-tsp-1 dsRNA for 7, 14 and 21 days caused 75% (p<0.001), 67% (p = 0.019) and 69% (p = 0.021) decreases in Sm-tsp-1 mRNA expression in comparison to the control group (Figure 4A). Larval parasites incubated with Sm-tsp-2 dsRNA for 7 days exhibited an 88% (p<0.001) decrease in Sm-tsp-2 transcript levels compared to luciferase dsRNA treated schistosomula (Figure 4B). RNAi knockdown was maintained with reductions of 82% (p = 0.004) and 69% (p = 0.021) at days 14 and 21, respectively, compared to the control group. As observed in adult worms, suppression of Sm-tsp RNAs resulted in no obvious phenotypic differences compared to the luciferase dsRNA-treated control group when examined by light microscopy. Cultures were visually inspected using a light microscope on a daily basis and no differences in early growth and development of schistosomula (development of intestinal ceca or size of schistosomula)  were apparent between test and control dsRNA treated groups.
Reduction in Sm-TSP2 protein expression in parasites treated with Sm-tsp-2 dsRNA
To determine whether knockdown of Sm-tsp-2 RNA was evident at the protein level, we performed Western blot analysis on dsRNA treated adult (Figure 5A) and larval (Figure 5B) parasites. Parasites were treated with Sm-tsp-2 or luciferase dsRNAs, lysed in 1% Triton X-100 and immunoblotted with anti-Sm-TSP-2 or anti-Sm-Pmy antibodies which target a sub-tegumental muscle protein, paramyosin . Sm-TSP-2 protein expression was decreased in adult worms treated with Sm-tsp-2 dsRNA compared to worms treated with luciferase dsRNA for the four concentrations (2.0, 1.0, 0.5 and 0.25 µg) tested. In contrast, the Sm-Pmy protein expression levels did not change in both test and control groups. The experiment was repeated three times with similar results and a representative image is shown (Figure 5A). Densitometry analysis was performed on each band and the ratio of Sm-TSP-2 to Sm-Pmy at each concentration was calculated. Analysis of whole worm lysates (0.25 µg) by densitometry (not shown) revealed an average of 61% (p = 0.027) reduction in Sm-TSP-2 expression in adult worms treated with Sm-tsp-2 dsRNA compared to the control luciferase group. For RNAi treated schistosomula, the amount of Sm-TSP-2 protein expressed by schistosomula after 7 days in culture with Sm-tsp-2 dsRNA was reduced compared to parasites soaked in luciferase dsRNA (Figure 5B). Densitometry analysis of lysates (2 µg, 1 µg and 0.5 µg) showed an average decline of 36% (data not shown). This decrease was lower than expected since suppression of Sm-tsp-2 mRNA was more pronounced in schistosomula than in adult parasites. Adult and larval parasites soaked in Sm-tsp-1 dsRNA demonstrated no obvious differences in protein expression to luciferase dsRNA control worms by Western blotting analysis (data not shown).
Protein extracts from adult parasites (A) and schistosomula (B) treated with Sm-tsp-2 or luciferase dsRNAs for 7 days were loaded onto a 12% SDS-PAGE gel at 2, 1, 0.5 and 0.25 µg. Proteins were transferred onto nitrocellulose and immunoblotted with anti-Sm-TSP2 or anti-Sm-Pmy monoclonal antibodies. The intensity of paramyosin expression was evaluated to determine equal protein loading.
Suppression of Sm-tsp-2 mRNA results in malformation of the tegument when observed using transmission electron microscopy
Adult parasites and schistosomula treated with Sm-tsp-2 dsRNA in vitro displayed modified tegument structure when visualized with transmission electron microscopy (TEM) compared with luciferase dsRNA treated controls (Figure 6). The tegument of adult worms incubated in vitro in Sm-tsp-2 dsRNA (Figure 6C,E) was more highly vacuolated than luciferase dsRNA controls (Figure 6A), with extensive and enlarged vacuoles throughout the surface layer. The tegument of these parasites had less apparent cytoplasm and hence fewer cytoplasmic inclusions and was frequently much thinner than that of controls (Figure 6C,E). Schistosomula transformed and cultured in vitro presented a tegument that resembled that of larvae from natural or experimental infection (Figure 6B) . The tegument in Sm-tsp-2 dsRNA treated schistosomula (Figure 6D,F) was consistently thinner than those of luciferase controls (P<0.001), measuring on average 0.3784±0.016 µm compared with 0.5842±0.323 µm for luciferase controls (Figure 6G). Volume density measures for invaginations and clear vesicular compartments of the tegument showed higher volumes for these compartments in Sm-tsp-2 treated schistosomula (p = 0.014; Figure 6F). The morphology of the schistosomula tegument was consistent with a failure to close invaginations of the surface (Figure 6D,F). Adult worms and schistosomula soaked in Sm-tsp-1 dsRNA showed no obvious differences to luciferase dsRNA control worms when examined by transmission electron microscopy (data not shown).
A. Tegument of adult female treated with luciferase dsRNA. B. Tegument of schistosomulum incubated for 7 days with luciferase dsRNA. C and E. Tegument of adult female incubated with Sm-tsp-2 dsRNA. The tegument is more highly vacuolated (C) and thinner (E) compared with controls. D and F. Tegument of schistosomula incubated for 7 days with Sm-tsp-2 dsRNA. Digitate extensions (arrows) are more abundant on the surface of the tegument. Abbreviations: Mus-muscles; teg-surface layer of tegument. The tegument of schistosomula were thinner, p<0.001 (G) and more dense, p = 0.014 (H) in Sm-tsp-2 dsRNA treated schistosomula.
Suppression of Sm-tsp mRNAs in schistosomula affects parasite survival in vivo
In the mammalian host, larval schistosomes migrate from the skin through the lungs to the liver and then mature in the mesenteric veins . In an effort to mimic in vivo conditions, 3 h schistosomula were electroporated with 100 µg/ml of Sm-tsp-1, Sm-tsp-2 or luciferase dsRNA and then injected intramuscularly into female C57BL/6 mice. Four weeks later mice were perfused to determine the number of parasites that reached maturity in the mesenteries. Significantly fewer parasites were recovered from the mesenteric veins compared to the luciferase control group (see Figure 7A for results of three experiments). Mice injected with schistosomula that were electroporated with Sm-tsp-1 dsRNA yielded 48% (p = 0.045), 60% (p = 0.009) and 67% (p = 0.019) reduction in the number of parasites recovered for Experiments 1, 2 and 3, respectively in comparison to the luciferase control group. Schistosomula pretreated with Sm-tsp-2 dsRNA and then injected into mice resulted in 70% (p = 0.039), 91% (p = 0.009) and 78% (p = 0.018) decreases in parasite survival for Experiments 1, 2 and 3, respectively when compared to the luciferase dsRNA group. The numbers of mature worms harvested from the luciferase control group were very low, with recovery ranging from 0.5-1.5%, however the data was consistent between three experiments, with a reproducible and significant reduction in worm recovery rates between tsp and luciferase dsRNA treated parasites.
Schistosomula were electroporated with 100 µg/ml of Sm-tsp-1, Sm-tsp-2 or luciferase dsRNAs, washed and counted. C57BL/6 female mice were immunized intramuscularly with 2,000 dsRNA treated schistosomula and were perfused 4 weeks later to determine parasite numbers (A). Expression of Sm-tsp-1 and Sm-tsp-2 mRNA transcript levels of parasites harvested from Experiment 1 (B). The Sm-tsp-1 and Sm-tsp-2 transcript levels of schistosomula that were electroporated and concurrently cultured in vitro for 4 weeks were also determined (C).
RNA was extracted from surviving worms that were perfused from mice and transcript levels were analyzed by qRT-PCR. Sm-tsp-1 expression was only slightly lower (17%) in worms recovered from mice that were infected with Sm-tsp-1 dsRNA-treated schistosomula compared to the control group. Likewise, Sm-tsp-2 expression was slightly reduced (15%) in worms recovered from mice that were infected with Sm-tsp-2 dsRNA treated worms compared to the luciferase control group (Figure 7B). However, when the same batch of dsRNA electroporated schistosomula were cultured in vitro for the same period of time (4 weeks), as opposed to being injected into mice, significant knockdown of Sm-tsp-1 and Sm-tsp-2 transcripts by 58% and 87%, respectively (Figure 7C), was observed. These results illustrate that silencing of Sm-tsp-1 and Sm-tsp-2 by either soaking or electroporation leads to suppression of tetraspanin genes in schistosomes, and suppression is maintained for at least 4 weeks in culture. The data also implies one of three possible outcomes for Sm-tsp dsRNA treated schistosomula that survived to adulthood after being transferred into mice; (1) RNAi was not as effective in those individual schistosomula that survived in mice as opposed to those that perished; (2) some of the RNAi treated parasites received (or took up) less dsRNA, and therefore the efficacy of gene suppression was variable between individuals in a single electroporated batch; (3) it is also possible that host developmental cues stimulate transcription.
Schistosomes express a family of tetraspanins in their tegument. Sm23 was the first tetraspanin identified in S. mansoni , and is of interest as a DNA vaccine antigen against schistosomiasis . Its orthologue from S. japonicum, Sj23, protects water buffaloes against challenge infection when administered as a DNA vaccine . We identified two additional tetraspanins, Sm-tsp-1 and Sm-tsp-2, which showed high levels of protection when administered to mice as recombinant protein vaccines against S. mansoni , . However, despite the protective efficacy that these tetraspanins afford, their functions in the parasite are unknown. To understand the roles that these proteins play in the schistosome tegument, we herein explored the effects of silencing the expression of Sm-tsp-1 and Sm-tsp-2 mRNAs in adult and larval S. mansoni.
RNAi has been used to suppress a number of schistosome genes in an effort to determine their functions , . Soaking of S. mansoni with dsRNA encoding the intestinal protease cathepsin B (SmCB1), resulted in greater than 10-fold decrease in SmCB1 mRNA levels and significant growth inhibition compared to parasites treated with control dsRNA . Suppression of the mRNA encoding another intestinal protease, S. mansoni cathepsin D (SmCD), in schistosomula by electroporation with dsRNA led to reduction in RNA transcript levels, growth retardation in vitro and in vivo, and decreased cathepsin D enzymatic activity . Silencing of the SmAQP gene encoding a water channel protein by electroporating schistosomula with short interfering RNAs suppressed mRNA and protein expression in the tegument, and treated parasites cultured in vitro exhibited stunted growth and lower viability . RNAi has been used to determine the functional importance of tetraspanins in other organisms . Suppression of tetraspanin-15 mRNA by feeding C. elegans with dsRNA resulted in dissociation of the cuticle and degeneration of the hypodermis, compromising epidermal integrity . RNAi has also been used to determine the function of human tetraspanins in various cell types . For example, the CD151 tetraspanin interacts with membrane proteins including the laminin-binding integrin α3β1; when lung adenocarcinoma cells were cultured on laminin-511 and then treated with CD151 siRNA, abnormal membrane protrusions on laminin-511 were apparent and tyrosine phosphorylation dependent signalling was reduced . These findings indicate a role for tetraspanins in the maintenance of cell membrane biogenesis and structural integrity, and support our observations on the compromised tegument membrane formation in S. mansoni when tsp mRNA expression is suppressed.
Numerous reports have documented molecular interactions between tetraspanins and MHC, and involvement of human tetraspanins in regulating T cell co-stimulation and peptide/MHC presentation , , , indicating additional, non-structural roles. Schistosomes acquire host MHC onto their surfaces , presenting the intriguing possibility that they function as a receptor for host MHC. However, the majority of mammalian tetraspanin binding partners identified to date are membrane proteins rather than extracellular ligands ; moreover, our data presented here implies that schistosome tetraspanins are pivotal for proper tegument formation, even during in vitro culture in the absence of immune cells, supporting a structural role in the establishment and maintenance of the tegument. Indeed, the tetraspanin CD9 complexes with numerous proteins including Ig-containing proteins , a family of proteins which are also present in the S. mansoni tegument membrane . Various authors have described the contribution of tetraspanins, such as CD9 and CD151, with members of the integrin family in promoting cell-cell interactions and migration , , . Mass spectrometric analysis of the S. mansoni tegument revealed a β-integrin subunit in the sub-tegumental layer . Suppression of tetraspanin mRNA expression in schistosomes may affect lateral interactions with integrins in the tegument, and the parasite's ability to migrate through the lungs to the liver and mesenteries where they would mature. The binding partner(s) associated with Sm-TSP-1 or Sm-TSP-2, or any of the other three S. mansoni tegument tetraspanins, have yet to be identified. We have produced monoclonal antibodies to Sm-TSP-2 and these antibodies are being used to immunoprecipitate Sm-TSP-2 and its binding partners in an effort to unravel the tegumental tetraspanin web.
To assess the viability of dsRNA treated parasites in vivo, we injected tsp or luciferase dsRNA treated parasites into mice via the intramuscular route . Recovery of adult worms from the mesenteries 4 weeks later was very low but was in agreement with other reports where newly transformed schistosomula were electroporated with dsRNAs prior to intramuscular injection into mice and subsequent recovery of adult worms from the mesenteries . The natural route of S. mansoni infection is through percutaneous penetration of cercariae; exposure of laboratory mice to cercariae is generally performed via the abdomen or tail. Intramuscular injection of mice with schistosomula is not the natural infection route and consequently may have contributed to the low recovery rates. Despite the low recovery of adult parasites, we consistently over three experiments recovered significantly fewer worms from the mice injected with tsp dsRNA treated parasites. Moreover, tsp mRNA levels in those parasites that were recovered from mice were higher than levels in parasites cultured in vitro for the same time period after electroporation with dsRNAs, indicating that the parasites that survived in vivo had not succumbed to the effects of RNAi.
We envisage that interruption of Sm-TSP-1 and TSP-2 protein expression in the tegument of maturing schistosomula results in impaired turnover of the tegument apical membrane complex. Our observations from adults and schistosomula treated with Sm-tsp-2 dsRNA would indicate that a likely role for Sm-tsp-2 is in invagination and internalization of the surface membrane, and perhaps the closure and internalization of surface invaginations. This postulate is consistent with the suggestion that TSP-2 binds other parasite sub-surface and surface molecules in the tegument. The vaccine efficacy of TSP-2 may thus result from impairment of the surface recycling mechanisms in developing and adult schistosomes. While this impaired surface turnover was not deleterious to in vitro cultivated adult worms and schistosomula, the effect was particularly marked in treated schistosomula transferred into the host. In addition, schistosomes have the capacity to adsorb host blood molecules that mask antigenic epitopes from the host's immune system . By affecting surface tegument development and turnover, suppression of tsp expression (and potential disruption of TEMs) may render the organism susceptible to immune recognition and clearance.
Materials and Methods
All animals were maintained in accordance with the guidelines of the Animal Ethics Committee (AEC) of Queensland Institute of Medical Research and the Institutional Animal Care and Use Committee (IACUC) of The University of Pennsylvania. All studies and procedures were reviewed and approved by the AEC and IACUC of Queensland Institute of Medical Research and The University of Pennsylvania respectively.
The Puerto Rican strain of S. mansoni and Biomphalaria glabrata snails were provided by the National Institutes of Allergy and Infectious Diseases Schistosomiasis Resource Centre at the Biomedical Research Institute (Rockville, Maryland, USA). B. glabrata infected with miracidia were exposed to incandescent light for 1h to obtain cercariae which were used to percutaneously infect 6–8 week old C57BL/6 female mice (www.jax.org). After 8 weeks, adult parasites were recovered by hepatic-portal perfusion and then washed three times with wash medium containing RPMI 1640, 1% antibiotic/antimycotic and 10 mM Hepes (www.invitrogen.com) before experimentation.
To obtain schistosomula, cercariae were passed through a 22-gauge emulsifying needle 25 times to mechanically shear the cercarial tails from the bodies . The resulting schistosomula were isolated from free tails by centrifugation through a 60% percoll gradient , washed three times with washing medium and incubated at 37°C under 5% CO2 atmosphere before experimentation.
Immunofluorescent labelling of live schistosomula
Three hour schistosomula (n = 500) were blocked in blocking buffer containing 1% goat serum in Dulbecco's Phosphate Buffered Saline (DPBS) containing MgCl2 and CaCl2 (www.invitrogen.com). Schistosomula were labelled with sera against recombinant Sm-TSP-1, Sm-TSP-2 or control pre-vaccination sera  diluted to 1∶50 in blocking buffer for 1 h. Secondary goat anti-mouse Ig-FITC (www.chemicon.com) was then introduced at 1∶100 dilution in blocking buffer for 1 h followed by 4% paraformaldehyde to fix the parasites. Incubations were carried out at 4°C and parasites were washed in DPBS between incubations. Approximately 200 schistosomula were examined using a Leica MRIRB microscope and DC500 camera (www.leica.com).
Synthesis of dsRNAs
dsRNAs were prepared from DNA templates that were amplified by PCR from S. mansoni paired adult worm cDNA using primers flanked with T7 RNA polymerase promoter sequence (underlined) at the 5′ ends. A 523 bp fragment of the Sm-tsp-1 coding DNA was generated using primers (forward: 5′-TAATACGACTCACTATAGGGACTTGCTTCGGGACAACAAC-3′, reverse: 5′-TAATACGACTCACTATAGGGTTCGAAAGCTGCAATAGAAACA-3′) and a 565 bp fragment of the Sm-tsp-2 coding DNA was produced using primers (forward: 5′-TAATACGACTCACTATAGGGTGATTGTGGTTGGTGCACTT-3′, reverse: 5′-TAATACGACTCACTATAGGGGACCAATGCGAACAGAAACA-3′). The GenBank accession numbers for Sm-tsp-1 and Sm-tsp-2 are AF521093 and AF521091, respectively. The PCR products were then utilized as templates for synthesis of dsRNAs using the T7 Megascript kit (www.ambion.com), following the manufacturer's instructions. An irrelevant negative control, firefly luciferase dsRNA derived from pGL3-basic (www.promega.com), was prepared as described previously .
dsRNA delivery in schistosomes
Adult schistosomes were cultured in vitro in Medium 199 (www.invitrogen.com) supplemented with 10% fetal calf serum (www.gembio.com), 1% antibiotic/antimycotic and 10 mM Hepes at 37°C under 5% CO2 atmosphere. Five pairs of adult worms were soaked in the presence of Sm-tsp-1, Sm-tsp-2 or luciferase dsRNAs at 1 µg/ml for 7 days with changes of media and dsRNAs every second day. Schistosomula were maintained at 37°C with 5% CO2 in Medium 169  supplemented with 10% human AB serum (www.gembio.com) and mouse whole blood. Larval parasites (3 h old) were soaked in 1 µg/ml of Sm-tsp-1, Sm-tsp-2 or luciferase dsRNAs and cultured in vitro at 37°C under 5% CO2 atmosphere for 7, 14 and 21 days, with fresh changes of media, blood and dsRNAs every second day. Adult and larval parasites were washed in wash medium prior to RNA or protein extraction.
Infection of mice with dsRNA-treated schistosomula
Newly transformed schistosomula were incubated in wash medium at 37°C with 5% CO2 for 3 h. Parasites were then resuspended in 50 µl of wash medium with 100 µg/ml of Sm-tsp-1, Sm-tsp-2 or luciferase dsRNAs and electroporated in a 4 mm cuvette at 125 V for 20 ms using a square-wave BTX ECM 830 electroporator (www.btxonline.com). After three washes in wash medium, schistosomula were counted and 2000 were injected intramuscularly into each C57BL/6 female mouse (3 mice per group) using a 23-gauge needle. Adult worms were perfused 28 days later to assess the number of worms that had matured and reached the mesenteries.
Real-time quantitative RT-PCR
RNA was isolated from parasites using RNeasy Mini kit (www.qiagen.com) and then treated with Turbo DNA-free endonuclease (www.ambion.com) to remove contaminating genomic DNA. The quantity of RNA was measured on a Nanodrop Spectrophotometer (www.nanodrop.com) and 250 ng of total RNA, SuperScript II reverse transcriptase (www.invitrogen.com) and oligo dT15 primer (www.promega.com) were used to synthesize first strand cDNA.
The following primers were designed for real-time qRT-PCR; Sm-TSP-1 (forward: 5′-TGGTTGTGCTTATTGGGTTG-3′ and reverse: 5′-TGATGTCTTGTGCCTCTGGT-3′); Sm-TSP-2 (forward: 5′-CGAAATTGAACCCCCACTAC-3′ and revere: 5′-CATGCTCCAAACATCCCTAAA-3′); Sm-Paramyosin (forward: 5′-CGTGAAGGTCGTCGTATGGT-3′ and reverse 5′-GACGTTCAAATTTACGTGCTTG-3′) and Sm-α-tubilin (forward: 5′-CCAGCAAAATCAGATGGTGAA-3′ and reverse: 5′-TTGACATCCTTGGGGACAAC-3′). qRT-PCR was conducted in triplicate and each reaction underwent 40 amplification cycles using an Applied Biosystems 7500 real-time PCR system (www.appliedbiosystems.com) with cDNA equivalent to 20 ng of total RNA, 50 nM of primers and SYBR green PCR Master Mix (www.appliedbiosystems.com). Dissociation curves were generated for each sample to verify the amplification of a single PCR product. Sm-tsp transcript levels were calculated relative to Sm-paramyosin in test and irrelevant dsRNA treated parasites using the 2−ΔΔCt method , and data was expressed as percent differences. For relative endogenous expression of tsp mRNAs in schistosome life cycle stages, Sm-α-tubulin was used as the endogenous standard. Sm-paramyosin was used as the housekeeping gene for analyzing Sm-tsp expression in RNAi experiments.
Evaluation of protein expression
RNAi-treated adult parasites and schistosomula were harvested after 7 days and then lysed with 1% Triton X-100 in Tris buffered saline supplemented with complete protease inhibitor cocktail EASYpacks (www.roche.com). Protein concentrations of lysates were determined using a BCA protein assay kit (www.pierce.com), and lysates were electrophoresed in 12% SDS-PAGE gels at concentrations of 2, 1, 0.5 and 0.25 µg total protein per well. Proteins were transferred to nitrocellulose membrane (Hybond-ECL, www.gehealthcare.com) and then probed with either anti-Sm-TSP-2 (3H5/2) monoclonal antibody supernatants (L. Cooper, M. Tran and A. Loukas, unpublished) diluted 1∶1,000 followed by anti-mouse Ig-HRP (www.chemicon.com) diluted 1∶5,000. Reactive proteins were detected by ECL (www.gehealthcare.com) as per the manufacturer's instructions. To assess equal protein loading, nitrocellulose membranes were stripped after reacting with anti-TSP-2 antibodies and then re-probed with anti-paramyosin (Sm4B1) monoclonal antibody supernatants  diluted at 1∶1,000 followed by anti-mouse Ig-HRP. Experiments were repeated three times and protein quantities in gel bands were determined using Syngene Tools and software (www.syngene.com).
Adult parasites and schistosomula were soaked in 1 µg/ml of Sm-tsp or luciferase dsRNAs for 7 days at 37°C under 5% CO2 atmosphere, washed three times in wash medium and then fixed in 3% glutaradehyde in 0.1M phosphate buffer at pH 7.4, followed by fixation in potassium ferricyanide-reduced osmium tetroxide. After fixation, parasites were dehydrated in acetone and embedded in Epon Resin (ProSciTech). Ultrathin sections were mounted onto copper grids, contrasted in uranyl acetate and lead citrate and examined and photographed using a JEM 1011 transmission electron microscope operated at 80 kV and equipped with a digital camera.
A morphometric approach was employed to quantify possible changes to tegument structure in schistosomula treated with Sm-tsp-2 relative to those treated with luciferase dsRNA. Point counting stereology ,  was used to measure the volume of tegument occupied by vacuolar compartments or tegument invaginations in the tegument. Such regions were evident as clear spaces in TEM sections. Twenty individual schistosomula were selected at low magnification in the TEM. For each parasite, the first region of tegument observed that fulfilled the two criteria below was photographed at ×10,000 magnification. Criteria for selection were, firstly, that the region photographed was from the lateral aspect of a parasite that was clearly longer than wide and in which internal organs were present, and secondly, that the region was not excessively spinous. Volume density of vacuolar compartments of tegument were estimated using grids generated by Image J analysis software (NIH Besthesda), and were calculated as the number of points on the grid intersecting a vacuolar space divided by the number of points intersecting the tegument. This was measured across the entire profile of the tegument in each electron micrograph, so that only one measure was obtained for each schistosomulum. In addition to the volume density measure, the thickness of the tegument was measured at 10 different points using the line tool in Image J. For each measure, a line was drawn digitally on each micrograph from the basal membrane of the tegument to the apical membrane. Regions where the tegument was excessively invaginated, and those containing isolated spines and sensory receptors were not measured. The 10 thickness measurements were averaged for each schistosomulum.
All data are presented as the mean±standard error. Differences between groups were assessed for statistical significance using Student t-test (GraphPad Prism Software, www.graphpad.com). A statistically significant difference for a particular comparison was defined as p<0.050.
We thank Euihye Jung and Sarah E Galanti (University of Pennsylvania) for technical assistance and advice, and Mary Duke (Queensland Institute of Medical Research) and Fred Lewis (Biomedical Research Facility) for their support in maintaining the schistosome life cycle. We also thank Sujeevi Nawaratna for carrying out electron microscopy processes.
Conceived and designed the experiments: MHT TCF MKJ EJP AL. Performed the experiments: MHT TCF LC SG EL. Analyzed the data: MHT MLG MKJ EL. Contributed reagents/materials/analysis tools: SG MLG MKJ EJP. Wrote the paper: MHT EJP AL.
- 1. Fenwick A, Rollinson D, Southgate V (2006) Implementation of human schistosomiasis control: Challenges and prospects. Adv Parasitol 61: 567–622.A. FenwickD. RollinsonV. Southgate2006Implementation of human schistosomiasis control: Challenges and prospects.Adv Parasitol61567622
- 2. Gryseels B, Polman K, Clerinx J, Kestens L (2006) Human schistosomiasis. Lancet 368: 1106–1118.B. GryseelsK. PolmanJ. ClerinxL. Kestens2006Human schistosomiasis.Lancet36811061118
- 3. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411–425.P. SteinmannJ. KeiserR. BosM. TannerJ. Utzinger2006Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk.Lancet Infect Dis6411425
- 4. Miller P, Wilson RA (1980) Migration of the schistosomula of Schistosoma mansoni from the lungs to the hepatic portal system. Parasitology 80: 267–288.P. MillerRA Wilson1980Migration of the schistosomula of Schistosoma mansoni from the lungs to the hepatic portal system.Parasitology80267288
- 5. Jones MK, Gobert GN, Zhang L, Sunderland P, McManus DP (2004) The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions. Bioessays 26: 752–765.MK JonesGN GobertL. ZhangP. SunderlandDP McManus2004The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions.Bioessays26752765
- 6. Smithers SR, McLaren DJ, Ramalho-Pinto FJ (1977) Immunity to schistosomes: the target. Am J Trop Med Hyg 26: 11–19.SR SmithersDJ McLarenFJ Ramalho-Pinto1977Immunity to schistosomes: the target.Am J Trop Med Hyg261119
- 7. Smithers SR, Terry RJ (1976) The immunology of schistosomiasis. Adv Parasitol 14: 399–422.SR SmithersRJ Terry1976The immunology of schistosomiasis.Adv Parasitol14399422
- 8. Loukas A, Tran M, Pearson MS (2007) Schistosome membrane proteins as vaccines. Int J Parasitol 37: 257–263.A. LoukasM. TranMS Pearson2007Schistosome membrane proteins as vaccines.Int J Parasitol37257263
- 9. Verjovski-Almeida S, DeMarco R, Martins EA, Guimaraes PE, Ojopi EP, et al. (2003) Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet 35: 148–157.S. Verjovski-AlmeidaR. DeMarcoEA MartinsPE GuimaraesEP Ojopi2003Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni.Nat Genet35148157
- 10. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, et al. (2009) The genome of the blood fluke Schistosoma mansoni. Nature 460: 352–358.M. BerrimanBJ HaasPT LoVerdeRA WilsonGP Dillon2009The genome of the blood fluke Schistosoma mansoni.Nature460352358
- 11. Braschi S, Curwen RS, Ashton PD, Verjovski-Almeida S, Wilson A (2006) The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics 6: 1471–1482.S. BraschiRS CurwenPD AshtonS. Verjovski-AlmeidaA. Wilson2006The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction.Proteomics614711482
- 12. Gaugitsch HW, Hofer E, Huber NE, Schnabl E, Baumruker T (1991) A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur J Immunol 21: 377–383.HW GaugitschE. HoferNE HuberE. SchnablT. Baumruker1991A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23.Eur J Immunol21377383
- 13. Smyth D, McManus DP, Smout MJ, Laha T, Zhang W, et al. (2003) Isolation of cDNAs encoding secreted and transmembrane proteins from Schistosoma mansoni by a signal sequence trap method. Infect Immun 71: 2548–2554.D. SmythDP McManusMJ SmoutT. LahaW. Zhang2003Isolation of cDNAs encoding secreted and transmembrane proteins from Schistosoma mansoni by a signal sequence trap method.Infect Immun7125482554
- 14. Braschi S, Borges WC, Wilson RA (2006) Proteomic analysis of the schistosome tegument and its surface membranes. Mem Inst Oswaldo Cruz 101: Suppl 1205–212.S. BraschiWC BorgesRA Wilson2006Proteomic analysis of the schistosome tegument and its surface membranes.Mem Inst Oswaldo Cruz101Suppl 1205212
- 15. Kovalenko OV, Metcalf DG, DeGrado WF, Hemler ME (2005) Structural organization and interactions of transmembrane domains in tetraspanin proteins. BMC Struct Biol 5: 11.OV KovalenkoDG MetcalfWF DeGradoME Hemler2005Structural organization and interactions of transmembrane domains in tetraspanin proteins.BMC Struct Biol511
- 16. Hemler ME (2001) Specific tetraspanin functions. J Cell Biol 155: 1103–1107.ME Hemler2001Specific tetraspanin functions.J Cell Biol15511031107
- 17. Stipp CS, Kolesnikova TV, Hemler ME (2003) Functional domains in tetraspanin proteins. Trends Biochem Sci 28: 106–112.CS StippTV KolesnikovaME Hemler2003Functional domains in tetraspanin proteins.Trends Biochem Sci28106112
- 18. Boucheix C, Duc GH, Jasmin C, Rubinstein E (2001) Tetraspanins and malignancy. Expert Rev Mol Med . 2001. : 1–17.C. BoucheixGH DucC. JasminE. Rubinstein2001Tetraspanins and malignancy.Expert Rev Mol Med 2001117
- 19. Hemler ME (2003) Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 19: 397–422.ME Hemler2003Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain.Annu Rev Cell Dev Biol19397422
- 20. Wright MD, Moseley GW, van Spriel AB (2004) Tetraspanin microdomains in immune cell signalling and malignant disease. Tissue Antigens 64: 533–542.MD WrightGW MoseleyAB van Spriel2004Tetraspanin microdomains in immune cell signalling and malignant disease.Tissue Antigens64533542
- 21. Higginbottom A, Takahashi Y, Bolling L, Coonrod SA, White JM, et al. (2003) Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusion. Biochem Biophys Res Commun 311: 208–214.A. HigginbottomY. TakahashiL. BollingSA CoonrodJM White2003Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusion.Biochem Biophys Res Commun311208214
- 22. Lazo PA (2007) Functional implications of tetraspanin proteins in cancer biology. Cancer Sci 98: 1666–1677.PA Lazo2007Functional implications of tetraspanin proteins in cancer biology.Cancer Sci9816661677
- 23. Rubinstein E, Ziyyat A, Prenant M, Wrobel E, Wolf JP, et al. (2006) Reduced fertility of female mice lacking CD81. Dev Biol 290: 351–358.E. RubinsteinA. ZiyyatM. PrenantE. WrobelJP Wolf2006Reduced fertility of female mice lacking CD81.Dev Biol290351358
- 24. Barraud-Lange V, Naud-Barriant N, Bomsel M, Wolf JP, Ziyyat A (2007) Transfer of oocyte membrane fragments to fertilizing spermatozoa. FASEB J 21: 3446–3449.V. Barraud-LangeN. Naud-BarriantM. BomselJP WolfA. Ziyyat2007Transfer of oocyte membrane fragments to fertilizing spermatozoa.FASEB J2134463449
- 25. Gordon-Alonso M, Yanez-Mo M, Barreiro O, Alvarez S, Munoz-Fernandez MA, et al. (2006) Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion. J Immunol 177: 5129–5137.M. Gordon-AlonsoM. Yanez-MoO. BarreiroS. AlvarezMA Munoz-Fernandez2006Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion.J Immunol17751295137
- 26. Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, et al. (2003) Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278: 41624–41630.B. BartoschA. VitelliC. GranierC. GoujonJ. Dubuisson2003Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.J Biol Chem2784162441630
- 27. Yalaoui S, Zougbede S, Charrin S, Silvie O, Arduise C, et al. (2008) Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain. PLoS Pathog 4: e1000010.S. YalaouiS. ZougbedeS. CharrinO. SilvieC. Arduise2008Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain.PLoS Pathog4e1000010
- 28. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nature Med 12: 835–840.MH TranMS PearsonJM BethonyDJ SmythMK Jones2006Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis.Nature Med12835840
- 29. van Balkom BW, van Gestel RA, Brouwers JF, Krijgsveld J, Tielens AG, et al. (2005) Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome. J Proteome Res 4: 958–966.BW van BalkomRA van GestelJF BrouwersJ. KrijgsveldAG Tielens2005Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome.J Proteome Res4958966
- 30. Braschi S, Wilson RA (2006) Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics 5: 347–356.S. BraschiRA Wilson2006Proteins exposed at the adult schistosome surface revealed by biotinylation.Mol Cell Proteomics5347356
- 31. Correnti JM, Pearce EJ (2004) Transgene expression in Schistosoma mansoni: introduction of RNA into schistosomula by electroporation. Mol Biochem Parasitol 137: 75–79.JM CorrentiEJ Pearce2004Transgene expression in Schistosoma mansoni: introduction of RNA into schistosomula by electroporation.Mol Biochem Parasitol1377579
- 32. Skelly PJ, Da'dara A, Harn DA (2003) Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference. Int J Parasitol 33: 363–369.PJ SkellyA. Da'daraDA Harn2003Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference.Int J Parasitol33363369
- 33. Freitas TC, Jung E, Pearce EJ (2007) TGF-beta signaling controls embryo development in the parasitic flatworm Schistosoma mansoni. PLoS Pathog 3: e52.TC FreitasE. JungEJ Pearce2007TGF-beta signaling controls embryo development in the parasitic flatworm Schistosoma mansoni.PLoS Pathog3e52
- 34. Boyle JP, Wu XJ, Shoemaker CB, Yoshino TP (2003) Using RNA interference to manipulate endogenous gene expression in Schistosoma mansoni sporocysts. Mol Biochem Parasitol 128: 205–215.JP BoyleXJ WuCB ShoemakerTP Yoshino2003Using RNA interference to manipulate endogenous gene expression in Schistosoma mansoni sporocysts.Mol Biochem Parasitol128205215
- 35. Hockley DJ, McLaren DJ (1973) Schistosoma mansoni: changes in the outer membrane of the tegument during development from cercaria to adult worm. Int J Parasitol 3: 13–25.DJ HockleyDJ McLaren1973Schistosoma mansoni: changes in the outer membrane of the tegument during development from cercaria to adult worm.Int J Parasitol31325
- 36. Basch PF (1981) Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and development until pairing. J Parasitol 67: 179–185.PF Basch1981Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and development until pairing.J Parasitol67179185
- 37. Schmidt J, Bodor O, Gohr L, Kunz W (1996) Paramyosin isoforms of Schistosoma mansoni are phosphorylated and localized in a large variety of muscle types. Parasitology 112: 459–467.J. SchmidtO. BodorL. GohrW. Kunz1996Paramyosin isoforms of Schistosoma mansoni are phosphorylated and localized in a large variety of muscle types.Parasitology112459467
- 38. Cousin CE, Stirewalt MA, Dorsey CH, Watson LP (1986) Schistosoma mansoni: comparative development of schistosomules produced by artificial techniques. J Parasitol 72: 606–609.CE CousinMA StirewaltCH DorseyLP Watson1986Schistosoma mansoni: comparative development of schistosomules produced by artificial techniques.J Parasitol72606609
- 39. Da'dara AA, Li YS, Xiong T, Zhou J, Williams GM, et al. (2008) DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 26: 3617–3625.AA Da'daraYS LiT. XiongJ. ZhouGM Williams2008DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo.Vaccine2636173625
- 40. Ndegwa D, Krautz-Peterson G, Skelly PJ (2007) Protocols for gene silencing in schistosomes. Exp Parasitol 117: 284–291.D. NdegwaG. Krautz-PetersonPJ Skelly2007Protocols for gene silencing in schistosomes.Exp Parasitol117284291
- 41. Pearce EJ, Freitas TC (2008) Reverse genetics and the study of the immune response to schistosomes. Parasite Immunol 30: 215–221.EJ PearceTC Freitas2008Reverse genetics and the study of the immune response to schistosomes.Parasite Immunol30215221
- 42. Correnti JM, Brindley PJ, Pearce EJ (2005) Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol Biochem Parasitol 143: 209–215.JM CorrentiPJ BrindleyEJ Pearce2005Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth.Mol Biochem Parasitol143209215
- 43. Morales ME, Rinaldi G, Gobert GN, Kines KJ, Tort JF, et al. (2008) RNA interference of Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade. Mol Biochem Parasitol 157: 160–168.ME MoralesG. RinaldiGN GobertKJ KinesJF Tort2008RNA interference of Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade.Mol Biochem Parasitol157160168
- 44. Faghiri Z, Skelly PJ (2009) The role of tegumental aquaporin from the human parasitic worm, Schistosoma mansoni, in osmoregulation and drug uptake. FASEB J 23: 2780–2789.Z. FaghiriPJ Skelly2009The role of tegumental aquaporin from the human parasitic worm, Schistosoma mansoni, in osmoregulation and drug uptake.FASEB J2327802789
- 45. Hemler ME (2008) Targeting of tetraspanin proteins - potential benefits and strategies. Nature Rev Drug Discov 7: 747–758.ME Hemler2008Targeting of tetraspanin proteins - potential benefits and strategies.Nature Rev Drug Discov7747758
- 46. Moribe H, Yochem J, Yamada H, Tabuse Y, Fujimoto T, et al. (2004) Tetraspanin protein (TSP-15) is required for epidermal integrity in Caenorhabditis elegans. J Cell Sci 117: 5209–5220.H. MoribeJ. YochemH. YamadaY. TabuseT. Fujimoto2004Tetraspanin protein (TSP-15) is required for epidermal integrity in Caenorhabditis elegans.J Cell Sci11752095220
- 47. Yamada M, Sumida Y, Fujibayashi A, Fukaguchi K, Sanzen N, et al. (2008) The tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin-511. FEBS J 275: 3335–3351.M. YamadaY. SumidaA. FujibayashiK. FukaguchiN. Sanzen2008The tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin-511.FEBS J27533353351
- 48. Szollosi J, Horejsi V, Bene L, Angelisova P, Damjanovich S (1996) Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol 157: 2939–2946.J. SzollosiV. HorejsiL. BeneP. AngelisovaS. Damjanovich1996Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.J Immunol15729392946
- 49. Kropshofer H, Spindeldreher S, Rohn TA, Platania N, Grygar C, et al. (2002) Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nature Immunol 3: 61–68.H. KropshoferS. SpindeldreherTA RohnN. PlataniaC. Grygar2002Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.Nature Immunol36168
- 50. Sheng KC, van Spriel AB, Gartlan KH, Sofi M, Apostolopoulos V, et al. (2009) Tetraspanins CD37 and CD151 differentially regulate Ag presentation and T-cell co-stimulation by DC. Eur J Immunol 39: 50–55.KC ShengAB van SprielKH GartlanM. SofiV. Apostolopoulos2009Tetraspanins CD37 and CD151 differentially regulate Ag presentation and T-cell co-stimulation by DC.Eur J Immunol395055
- 51. Sher A, Hall BF, Vadas MA (1978) Acquisition of murine major histocompatibility complex gene products by schistosomula of Schistosoma mansoni. J Exp Med 148: 46–57.A. SherBF HallMA Vadas1978Acquisition of murine major histocompatibility complex gene products by schistosomula of Schistosoma mansoni.J Exp Med1484657
- 52. Le Naour F, Andre M, Greco C, Billard M, Sordat B, et al. (2006) Profiling of the tetraspanin web of human colon cancer cells. Mol Cell Proteomics 5: 845–857.F. Le NaourM. AndreC. GrecoM. BillardB. Sordat2006Profiling of the tetraspanin web of human colon cancer cells.Mol Cell Proteomics5845857
- 53. Liu L, He B, Liu WM, Zhou D, Cox JV, et al. (2007) Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. J Biol Chem 282: 31631–31642.L. LiuB. HeWM LiuD. ZhouJV Cox2007Tetraspanin CD151 promotes cell migration by regulating integrin trafficking.J Biol Chem2823163131642
- 54. Yang XH, Richardson AL, Torres-Arzayus MI, Zhou P, Sharma C, et al. (2008) CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res 68: 3204–3213.XH YangAL RichardsonMI Torres-ArzayusP. ZhouC. Sharma2008CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.Cancer Res6832043213
- 55. Deissler H, Kuhn EM, Lang GE (2007) Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells. Int J Mol Med 20: 643–652.H. DeisslerEM KuhnGE Lang2007Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells.Int J Mol Med20643652
- 56. James ER, Taylor MG (1976) Transformation of cercariae to schistosomula: a quantitative comparison of transformation techniques and of infectivity by different injection routes of the organisms produced. J Helminthol 50: 223–233.ER JamesMG Taylor1976Transformation of cercariae to schistosomula: a quantitative comparison of transformation techniques and of infectivity by different injection routes of the organisms produced.J Helminthol50223233
- 57. Salafsky B, Fusco AC, Whitley K, Nowicki D, Ellenberger B (1988) Schistosoma mansoni: analysis of cercarial transformation methods. Exp Parasitol 67: 116–127.B. SalafskyAC FuscoK. WhitleyD. NowickiB. Ellenberger1988Schistosoma mansoni: analysis of cercarial transformation methods.Exp Parasitol67116127
- 58. Lazdins JK, Stein MJ, David JR, Sher A (1982) Schistosoma mansoni: rapid isolation and purification of schistosomula of different developmental stages by centrifugation on discontinuous density gradients of Percoll. Exp Parasitol 53: 39–44.JK LazdinsMJ SteinJR DavidA. Sher1982Schistosoma mansoni: rapid isolation and purification of schistosomula of different developmental stages by centrifugation on discontinuous density gradients of Percoll.Exp Parasitol533944
- 59. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.KJ LivakTD Schmittgen2001Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods25402408
- 60. Pearce EJ, James SL, Dalton J, Barrall A, Ramos C, et al. (1986) Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. J Immunol 137: 3593–3600.EJ PearceSL JamesJ. DaltonA. BarrallC. Ramos1986Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine.J Immunol13735933600
- 61. Griffiths G (1993) Fine Structure Immunocytochemistry. Berlin: Springer. 459 p.G. Griffiths1993Fine Structure ImmunocytochemistryBerlinSpringer459
- 62. Bartley PB, Ramm GA, Jones MK, Ruddell RG, Li Y, McManus DP (2006) A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Int J Parasitol 36: 993–1001.PB BartleyGA RammMK JonesRG RuddellY. LiDP McManus2006A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis.Int J Parasitol369931001